跳至主要内容
临床试验/DRKS00013735
DRKS00013735已完成未知

Effects of nicotinergic receptor stimulation with vareniclin on focal and non-focal plasticity in schizophrenia patients - Nikotin

Klinik für Psychiatrie und Psychotherapie- Klinikum der Universität München0 个研究点目标入组 61 人开始时间: 2018年1月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
61

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • ensured schizophrenia diagnosis (ICD-10)
  • - Age 18-65 years
  • - stable antipsychotic treatment with one or two (maximum) antipsychotic drugs
  • - Severity of the psychopathology is measured with PANSS and CGI. The PANSS Rating must be under a total of 75 Points (PANSS), CGI under a total of 4 points)
  • - Patients must be able to give consent and need to capable of understanding the declaration of consent (the doctors will check this for each patient)
  • - smokers (more than 10 cigarettes per day during the last 5 years)
  • - non-smokers (no consumption of tobacco products over the last 5 years)

排除标准

  • - acute suicidal tendencies or danger of harming others
  • - seizures or epileptic attacks in the past
  • - dermatological diseases
  • - metallic objects inside the head
  • - pregnancy
  • - intake of medication against epilepsy or depression
  • - Stable medication with Benzodiazepine
  • - addiction to alcohol or substances (not including tobacco)
  • - Patient has a legal carer who denies approval

研究者

发起方
Klinik für Psychiatrie und Psychotherapie- Klinikum der Universität München

相似试验

Effects of nicotinergic receptor stimulation with... | 临床试验